primary percutaneous coronary Intervention - Globe Thesis

Keyword [primary percutaneous coronary Intervention] Result: 41 - 60 \| Page: 3 of 10
41.	Intensive Atorvastatin Therapy To Prevent Contrast-induced Nephropathy In Patient With Acute St-segment Elevation Myocardial Infarction Undergoing Emergency Percutaneous Coronary Invention
42.	Cardioprotection Of Nicorandil In Patients With Acute Myocardial Infarction
43.	The Predictive Factors Of Poor Myocardial Perfusion And Contrast-induced Nephropathy For Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention And The Protective Effect Of Tirofiban And Anisodamine
44.	Study On Heart-kidney Protective Effects Of Anisodamine Combined With Statin In Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
45.	Study Of Effects Of Statin On Inflammatory Reaction And Cardiac Remodeling In Patients Diagnosed With Acute Myocardial Infarction Underwent Primary Percutaneous Coronary Intervention
46.	Study On Protective Effect Of Myocardium Reperfusion Using Anisodamine Combined With Nicorandil In Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention
47.	The Investigation On Application Of Thrombus In Primary Percutaneous Coronary Intervention For Patients With St-elevation Acute Myocardial Infarction Treatment Of Acute Myocardial Infarction
48.	Efficacy And Safety Of A Biodegradable Polymer-coated Sirolimus-eluting Stent Compares With Permanent Stent In Patients With Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
49.	Relation Between Red Blood Cell Distribution Width And The Prognosis In Patients Undergoing Primary Percutaneous Coronary Intervention For Acute Coronary Syndrome
50.	The Cardioprotection Study Of Earlier Nicorandil Administration In Patients With Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
51.	Comparison Of Zotarolimus-eluting Stents Versus Sirolimus-eluting Stents Versus Paclitaxel-eluting Stents For Primary Percutaneous Coronary Intervention:a Systematic Review
52.	Correlation Between Platelet Factors As Well As Hs-CRP And No-reflow In Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
53.	Effects Of Bivalirudin On Infarct Size In Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
54.	The Effects Of Anisodamine Combined With Ischemic Postconditioning On Myocardial Perfusion In Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
55.	The Preventive Effects Of Intracoronary Administration Of Anisodamine On Coronary Microcirculation After Primary Percutaneous Coronary Intervention In Acute Inferior Myocardial Infarction Patients
56.	The Impacts Of Difflerent Interventional Protocols On Recent Outcomes In No-reflow Patients With STEMI
57.	Comparative Effects Of Two Upstream Antiplatelet Strategies On Patients Underwent Primary Percutaneous Coronary Intervention
58.	Effects Of Intracoronary Tirofiban Before Or After The Coronary Opened On Myocardial Reperfusion In STEMI Patients Undergoing Primary PCI
59.	The Impact Of Intracoronary Diltiazem Application Via A Trans-formed Balloon Catheter To Coronary No Reflow Phenomenon During Primary Percutaneous Coronary Intervention For Acute ST Elevation Myocardial Infarction
60.	Effects Of Recombinant Human B-type Natriuretic Peptide At Early Reperfusion On Infarct Size In Patients With Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
<<First <Prev Next> Last>> Jump to